Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1986 Jan;21(1):75–77. doi: 10.1111/j.1365-2125.1986.tb02825.x

Inhibition of antipyrine elimination by disulfiram and cimetidine: the effect of concomitant administration.

S Loft, J Sonne, H Pilsgaard, M Døssing, E Poulsen
PMCID: PMC1400804  PMID: 3947507

Abstract

We investigated the effect of concomitantly administered disulfiram and cimetidine on antipyrine elimination. On day 1, 2, 4 and 6 of two periods of 6 days one sample antipyrine saliva clearance (APC) was measured in nine healthy volunteers. From day 2 to 6 of period I disulfiram 400 mg day-1 was administered and on day 5 and 6 cimetidine 1000 mg day-1 was added. In period II only cimetidine was given (on days 5 and 6). On day 4 of period II APC was increased 1.3 fold, probably due to self-induction by repeated antipyrine administration. Taking this into account disulfiram and cimetidine separately decreased APC 0.64 and 0.70 times, respectively. When both inhibitors were given APC was reduced 0.52 times. The results suggest that the effects of cimetidine and disulfiram on antipyrine elimination are additive.

Full text

PDF
75

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartle W. R., Walker S. E., Shapero T. Dose-dependent effect of cimetidine on phenytoin kinetics. Clin Pharmacol Ther. 1983 May;33(5):649–655. doi: 10.1038/clpt.1983.88. [DOI] [PubMed] [Google Scholar]
  2. Døssing M., Pilsgaard H., Rasmussen B., Poulsen H. E. Time course of phenobarbital and cimetidine mediated changes in hepatic drug metabolism. Eur J Clin Pharmacol. 1983;25(2):215–222. doi: 10.1007/BF00543794. [DOI] [PubMed] [Google Scholar]
  3. Døssing M., Poulsen H. E., Andreasen P. B., Tygstrup N. A simple method for determination of antipyrine clearance. Clin Pharmacol Ther. 1982 Sep;32(3):392–396. doi: 10.1038/clpt.1982.177. [DOI] [PubMed] [Google Scholar]
  4. Feely J., Pereira L., Guy E., Hockings N. Factors affecting the response to inhibition of drug metabolism by cimetidine--dose response and sensitivity of elderly and induced subjects. Br J Clin Pharmacol. 1984 Jan;17(1):77–81. doi: 10.1111/j.1365-2125.1984.tb05002.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ohnhaus E. E., Park B. K. Measurement of urinary 6-beta-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin. Eur J Clin Pharmacol. 1979 Mar 26;15(2):139–145. doi: 10.1007/BF00609878. [DOI] [PubMed] [Google Scholar]
  6. Pilsgaard H., Poulsen H. E. A one-sample method for antipyrine clearance determination in rats. Pharmacology. 1984;29(2):110–116. doi: 10.1159/000137999. [DOI] [PubMed] [Google Scholar]
  7. Sonne J., Døssing M., Loft S., Andreasen P. B. Antipyrine clearance in pneumonia. Clin Pharmacol Ther. 1985 Jun;37(6):701–704. doi: 10.1038/clpt.1985.117. [DOI] [PubMed] [Google Scholar]
  8. Vesell E. S., Passananti T., Glenwright P. A. Anomalous results of studies on drug interaction in man. III. Disulfiram and antipyrine. Pharmacology. 1975;13(6):481–491. doi: 10.1159/000136942. [DOI] [PubMed] [Google Scholar]
  9. Wallenstein S., Zucker C. L., Fleiss J. L. Some statistical methods useful in circulation research. Circ Res. 1980 Jul;47(1):1–9. doi: 10.1161/01.res.47.1.1. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES